- 2019-04-12 09:33Sterling Pharma to acquire CiVentiChem in the US
- 2019-04-12 09:33New China-based biotechs fueling growth in manufacturing across China
- 2019-04-12 09:33Herceptin has been Excellent over the Two Decades
- 2019-04-12 09:33Europe approves Lynparza in HER2-, gBRCAm advanced breast cancer
- 2019-04-12 09:33FDA green lights Amgen and UCB's Evenity in postmenopausal osteoporosis patients
-
- 2019-04-12 09:32FDA refuses Zogenix’s seizure drug Fintepla
- 2019-04-12 09:32Curcumin and pomegrantes - new hope for Alzheimer’s prevention?
- 2019-04-12 09:32Amgen’s Evenity FDA approved for osteoporosis in postmenopausal women
- 2019-04-11 08:51GSK named one of ‘top companies’ to work for in UK
- 2019-04-11 08:50FDA Approves First Single-Tablet, Two-Drug Treatment for Untreated HIV
-
- 2019-04-11 08:50ACell enters Chinese distribution agreement for wound management
- 2019-04-11 08:50GeneDesign joins Ajinomoto Bio-pharma
- 2019-04-11 08:50Immunomedics Announces Promotion Agreement With Janssen for Erdafitinib in the U.S.
- 2019-04-11 08:50Alkermes Announces Departure of Jim Robinson
- 2019-04-11 08:50United Therapeutics scraps development of esuberaprost after late-stage study failure in PAH
-
- 2019-04-11 08:50Shares in Zogenix plunge after FDA issues refuse-to-file letter for Fintepla as seizure treatment in
- 2019-04-10 09:06U.S. government forces Chinese divestiture in health data startup PatientsLikeMe: report
- 2019-04-10 09:05Drug linked to 33 deaths in Northern Ireland is reclassified
- 2019-04-10 09:05The top 15 pharma companies by 2018 revenue
- 2019-04-10 09:05Eppendorf AG increases sales and earnings in 2018 and accelerates organic growth
-
- 2019-04-10 09:05Wuhan University joins Landing enterprise for cervical cancer screening
- 2019-04-10 09:05I-Mab, Jiangsu Nhwa team up with Biodextris, Brigham to treat brain diseases
- 2019-04-10 09:05FDA declares 40 generics free of carcinogens as 'sartan' recalls continue
- 2019-04-10 09:05FDA expands approved use of metastatic breast cancer treatment to include male patients
- 2019-04-09 08:45FDA sends four warning letters for cGMP violations
-
- 2019-04-09 08:45Heart drugs free from carcinogens identified as recalls drag on
- 2019-04-09 08:45Brexit will have ‘minimal’ impact on R&D, expert says
- 2019-04-08 08:50Clinigen Completes Acquisition of US Rights to Proleukin
- 2019-04-08 08:50Former Insys sales exec to shell out $9.5M in opioid spray kickback scheme
- 2019-04-08 08:50BMS, clinging to Opdivo's lung cancer share, highlights long-term data
-
- 2019-04-08 08:50Kerry Wentworth appointed to MassBio Board of Directors
- 2019-04-08 08:50How Hot is the Third-generation EGFR-TKI?
- 2019-04-08 08:50FDA-approved drug effectively treats rare chronic immune disorder
- 2019-04-08 08:50Singapore recalls 3 brands of Losartan medicines
- 2019-04-08 08:50FDA-approved drug effectively treats rare chronic immune disorder
-
- 2019-04-08 08:50AVEO Oncology warns of "regulatory action" by EMA if overall survival results for Fotivda come up sh
- 2019-04-04 08:49Strides to launch Potassium Chloride Extended-Release tablets in the US market
- 2019-04-04 08:49Natural gene therapy for intractable skin disease discovered
- 2019-04-04 08:49New discoveries on bacterial viruses
- 2019-04-04 08:49Standigm raises $11.5M in Series B Round
-
- 2019-04-04 08:49As Merck Research Laboratories moves into new facility, 20 staffers get the ax
- 2019-04-04 08:49Selumetinib granted US Breakthrough Therapy Designation in neurofibromatosis type 1
- 2019-04-04 08:49FDA rejects approval of Evoke Pharma's Gimoti for diabetic gastroparesis
- 2019-04-04 08:49ADMA Biologics' shares surge after intravenous immune globulin drug product Asceniv gains FDA approv
- 2019-04-03 08:27BMS signs deal with Concerto HealthAI
-
- 2019-04-03 08:27NICE backs PredictImmune's IBD prognosis test
- 2019-04-03 08:27Boots tests ‘behavioural nudge theory’ for medication adherence
- 2019-04-03 08:27Fresh off new Farxiga data, AstraZeneca diabetes push points up cardiovascular, renal risks
- 2019-04-03 08:27No-deal Brexit could mean temporary medicines export ban
- 2019-04-03 08:27No-deal Brexit could mean temporary medicines export ban
-
- SunSirs: On February 19th, the Price of Imported Potassium Chloride Fell by 1.80%
- SunSirs: Costs Rose and Supply Increased, DOTP Prices Were Weak Consolidated after the Holiday
- SunSirs: After the Holiday, Plasticizer Manufacturers Resumed Production and DOP Supply Increased
- SunSirs: Costs Rose, Supply Increased, and DBP Prices Weakly Consolidated
- SunSirs: Poor Replenishment, the Price of Aluminum Fluoride Was Temporarily Stable after the Holiday
- SunSirs: On February 18th, the Domestic DBP Market Was Temporarily Stable
- SunSirs: The Price of Tetrachloroethylene Has Fallen Narrowly after the Hholiday, and Expectations A
- SunSirs: Demand Was Weak, Production Was Resumed, and Acetic Anhydride Prices Dropped after the Holi
- SunSirs: Demand Was Weak, Production Was Resumed, and Acetic Anhydride Prices Dropped after the Holi
- SunSirs: China Fuel Oil 180CST Market in 2024 may Maintain a Volatile Trend
- SunSirs: The Demand Varies, China Gasoline has Higher Resistance to Drop Compared to Diesel
- SunSirs: Just Entering February, the Dimethyl Carbonate Market Was Operating Steadily and Weakly
- SunSirs: The Market Price of Lithium Hydroxide Was Mainly Stable (January 29-February 5)
- SunSirs: The Price of Nitric Acid Had Dropped This Week (January 29-February 2)
- SunSirs : The Cement Market Prices in Hunan have been Declining fo rFour Consecutive Weeks
- SunSirs: As the New Year Approaching, the Trend of the Market for Isooctyl Acrylate
- SunSirs: The Domestic First-class Titanium Sponge Market Was Mainly Operating Weakly and Steadily (J
- SunSirs: The Market Price of Ferrous Lithium Phosphate Fell in January
- SunSirs: The Price of Sodium Metabisulfite Was Weaker in January
- SunSirs: China Domestic Ship Fuel Market Fluctuated and Rose in January, 2024
- SunSirs: The Lithium Hydroxide Market in January First Fell and Then Stabilized
- SunSirs: The NMP Market Weakly Declined in January
- SunSirs: Summary of Domestic Cobalt Market Trends on January 18th
- SunSirs: On January 18th, Prices of Some Domestic Dysprosium Terbium Series Products Increased
- SunSirs: The Potassium Carbonate Market Has Declined This Week (January 15-19)
- SunSirs: The Release of Demand Side Was Slow, and the Market for Isooctyl Acrylate Was Stable
- SunSirs: The Seamless Tube Market Had Been Operating Weakly and Steadily This Week (January 8-12)
- SunSirs: Sales Were Sluggish, Propane Continued to Decline
- SunSirs: Production and Sales are Weak, China DME Market is temporarily Stable
- SunSirs: Weak consolidation of China MTBE market